| Primary |
| Schizophrenia |
29.0% |
| Drug Use For Unknown Indication |
19.9% |
| Product Used For Unknown Indication |
18.1% |
| Psychotic Disorder |
6.2% |
| Schizophrenia, Paranoid Type |
5.8% |
| Schizoaffective Disorder |
4.4% |
| Bipolar Disorder |
2.7% |
| Ill-defined Disorder |
2.4% |
| Accidental Exposure |
1.9% |
| Depression |
1.8% |
| Hypertension |
1.3% |
| Insomnia |
1.0% |
| Anxiety |
0.9% |
| Constipation |
0.9% |
| Diabetes Mellitus |
0.8% |
| Foetal Exposure During Pregnancy |
0.7% |
| Drug Exposure During Pregnancy |
0.6% |
| Major Depression |
0.6% |
| Sleep Disorder |
0.5% |
| Affective Disorder |
0.5% |
|
| Death |
11.3% |
| Weight Increased |
10.1% |
| Injury Associated With Device |
9.1% |
| Hospitalisation |
7.9% |
| Psychotic Disorder |
7.0% |
| Treatment Noncompliance |
5.4% |
| Overdose |
5.2% |
| Completed Suicide |
4.9% |
| Suicidal Ideation |
4.7% |
| Inappropriate Schedule Of Drug Administration |
4.5% |
| Myocardial Infarction |
4.3% |
| Aggression |
3.4% |
| Pulmonary Embolism |
3.2% |
| Weight Decreased |
3.1% |
| Exposure To Contaminated Device |
2.9% |
| Suicide Attempt |
2.9% |
| Schizophrenia |
2.7% |
| Drug Ineffective |
2.6% |
| Condition Aggravated |
2.4% |
| Deep Vein Thrombosis |
2.4% |
|
| Secondary |
| Schizophrenia |
25.9% |
| Product Used For Unknown Indication |
17.0% |
| Schizophrenia, Paranoid Type |
13.9% |
| Drug Use For Unknown Indication |
8.3% |
| Bipolar Disorder |
7.6% |
| Psychotic Disorder |
4.8% |
| Major Depression |
4.4% |
| Schizoaffective Disorder |
3.6% |
| Bipolar I Disorder |
2.6% |
| Depression |
2.2% |
| Ill-defined Disorder |
2.0% |
| Hypertension |
1.5% |
| Insomnia |
1.2% |
| Sleep Disorder |
0.9% |
| Anxiety |
0.9% |
| Brain Injury |
0.9% |
| Constipation |
0.6% |
| Delusion |
0.6% |
| Parkinsonism |
0.6% |
| Acute Psychosis |
0.6% |
|
| Weight Increased |
15.9% |
| Treatment Noncompliance |
9.5% |
| Sleep Apnoea Syndrome |
9.1% |
| Inappropriate Schedule Of Drug Administration |
8.6% |
| Overdose |
6.1% |
| Weight Decreased |
5.8% |
| Death |
4.5% |
| Psychotic Disorder |
4.2% |
| Drug Ineffective |
3.9% |
| Schizophrenia |
3.9% |
| Suicidal Ideation |
3.8% |
| Diabetes Mellitus |
3.4% |
| Type 2 Diabetes Mellitus |
3.2% |
| Back Pain |
3.0% |
| Myalgia |
3.0% |
| Hospitalisation |
2.5% |
| Tardive Dyskinesia |
2.5% |
| Aggression |
2.4% |
| Completed Suicide |
2.4% |
| Dystonia |
2.4% |
|
| Concomitant |
| Schizophrenia |
30.2% |
| Product Used For Unknown Indication |
12.3% |
| Schizophrenia, Paranoid Type |
8.3% |
| Schizoaffective Disorder |
7.2% |
| Mental Disorder |
3.6% |
| Drug Use For Unknown Indication |
3.4% |
| Hepatitis C |
3.2% |
| Bipolar Disorder |
3.0% |
| Diabetes Mellitus |
3.0% |
| Psychotic Disorder |
3.0% |
| Sleep Disorder |
3.0% |
| Antidepressant Therapy |
2.6% |
| Depression |
2.5% |
| Ill-defined Disorder |
2.5% |
| Delusional Disorder, Unspecified Type |
2.3% |
| Hypertension |
2.3% |
| Insomnia |
2.3% |
| Constipation |
1.9% |
| Persecutory Delusion |
1.9% |
| Asperger's Disorder |
1.5% |
|
| Weight Increased |
10.7% |
| Overdose |
9.7% |
| Type 2 Diabetes Mellitus |
8.7% |
| White Blood Cell Count Decreased |
8.7% |
| Vomiting |
5.8% |
| Death |
4.9% |
| Metabolic Disorder |
4.9% |
| Pulmonary Embolism |
4.9% |
| Treatment Noncompliance |
4.9% |
| Hallucination, Auditory |
3.9% |
| Neutropenia |
3.9% |
| Sudden Death |
3.9% |
| Thrombosis |
3.9% |
| Wrong Technique In Drug Usage Process |
3.9% |
| Drug Ineffective |
2.9% |
| Extrapyramidal Disorder |
2.9% |
| Leukopenia |
2.9% |
| Myocardial Infarction |
2.9% |
| Pancytopenia |
2.9% |
| Psychotic Disorder |
2.9% |
|
| Interacting |
| Delusion |
26.8% |
| Major Depression |
26.8% |
| Schizophrenia, Paranoid Type |
24.4% |
| Schizophrenia |
14.6% |
| Nail Infection |
4.9% |
| Schizoaffective Disorder Bipolar Type |
2.4% |
|
| Vertigo |
55.0% |
| Pulmonary Embolism |
15.0% |
| Drug Interaction |
10.0% |
| Parkinsonism |
10.0% |
| Cerebral Haemorrhage |
5.0% |
| Extrapyramidal Disorder |
5.0% |
|
